Welcome and introduction (ID 4691)
Recent advances in ALK+ NSCLC (ID 4692)
Treatment selection and sequencing: decision making in 2021 (ID 4693)
The importance of managing CNS disease (ID 4694)
Optimising patient outcomes: treatment management options (ID 4695)
Wrap up and close (ID 4697)